Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€67.23
20.07.20
€88.00
04.11.21
-19.13%
21.03.21

Reichshofgabi 
20.07.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€68.40
24.05.20
€67.00
04.11.21
-24.90%
28.02.21

hmaurer 
24.05.20 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€75.80
03.05.20
€85.00
04.11.21
14.45%
12.02.21

Simon1 
03.05.20 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€226.30
20.01.21
€227.00
20.01.22
2.96%
02.02.21

Gilbert 
20.01.21 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€81.20
21.12.19
€90.00
04.11.21
13.05%
23.01.21

catos 
21.12.19 50%
buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€89.92
30.07.20
€125.00
04.11.21
44.97%
21.01.21

Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year
ValueFreak 
30.07.20 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€125.04
16.10.20
€120.00
04.11.21
4.56%
09.12.20

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
16.10.20 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€301.50
26.02.20
€295.00
04.11.21
-0.83%
05.11.20

Rouvenhey 
26.02.20 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€69.01
11.01.17
€79.38
14.09.20
83.42%
14.09.20

BastiBBC 
20.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€58.83
29.12.19
€65.00
15.07.20
15.06%
15.07.20

gordens 
29.12.19 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€124.42
26.01.20
€140.00
05.07.20
17.73%
05.07.20

fenjal 
26.01.20 50%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€41.54
18.04.19
€52.32
09.06.20
30.00%
09.06.20

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
fenjal 
14.08.19 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€64.39
25.03.20
€79.00
07.06.20
23.98%
07.06.20

fenjal 
25.03.20 50%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€74.46
16.05.18
€85.69
16.05.19
24.07%
16.05.19

klostergang 
23.08.19 50%
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€26.37
12.01.19
€27.24
30.01.19
5.28%
30.01.19

melinda 
18.08.19 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€336.00
02.12.18
€356.29
11.01.19
9.01%
11.01.19

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€32.06
19.07.18
€34.23
11.10.18
15.14%
11.10.18

exploration 
14.08.19 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€84.03
25.07.18
€96.51
07.09.18
15.54%
07.09.18

exploration 
14.08.19 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€312.09
10.03.18
€351.78
02.08.18
13.53%
02.08.18

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€276.91
13.05.18
€344.81
02.08.18
24.60%
02.08.18

piccolo90 
18.08.19 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€266.60
26.02.18
€288.64
06.07.18
21.37%
06.07.18

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€155.86
24.03.18
€166.87
04.06.18
8.04%
04.06.18

melinda 
18.08.19 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€73.17
11.05.18
€74.64
14.05.18
2.17%
14.05.18

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€67.07
07.02.18
€72.16
15.02.18
7.92%
15.02.18

melinda 
18.08.19 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€134.04
28.09.17
€144.32
05.02.18
9.74%
05.02.18

Could be worthwhile Investment >10% per year
melinda 
14.08.19 50%